1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 924 F.Supp.2d
  5. 924 F.Supp.2d 1099 (2013)
 

MESSICK v. NOVARTIS PHARMACEUTICALS CORP.

No. CV 12-00693 SI.

924 F.Supp.2d 1099 (2013)

Linda MESSICK, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORP., Defendant.

United States District Court, N.D. California.

February 15, 2013.

Attorney(s) appearing for the Case

Bart T. Valad , Law Firm of Bart T. Valad, PLLC, John J. Vecchione , Valad & Vecchione, PLLC, Fairfax, VA, Cheryl Pauline Robertson , John A. Girardi , Molly Beth Weber , Girardi and Keese, Los Angeles, CA, Lyn K. Broom , Teague, Rotenstreich & Stanaland, Greensboro, NC, Robert G. Germany , Pittman, Germany, Roberts & Welsh, LLP, Jackson, MS, for Plaintiff.

James A. Bruen , James H. Colopy , Farella Braun and Martel LLP, San Francisco, CA, Bruce J. Berger , Frank Leone, Jr. , Katharine R. Latimer , Matthew J. Malinowski , Philip Marshal Busman , Robert E. Johnston , Hollingsworth LLP, Washington, DC, for Defendant.

ORDER GRANTING DEFENDANT'S DAUBERT MOTION TO EXCLUDE CAUSATION TESTIMONY AND MOTION FOR SUMMARY JUDGMENT

SUSAN ILLSTON, District Judge.

In June 2011, while this action was pending in the Middle District of Tennessee for pretrial proceedings as part of MDL No. 1760 (In re Aredia and Zometa Products Liability Litigation), defendant Novartis Pharmaceuticals Corp. filed a Daubert motion to exclude specific...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases